BACKGROUND
According to recent estimates, splice site defects account for 5% to 10% of pathogenic mutations causing Mendelian diseases. The prevalence is even higher for neuromuscular disorders (NMDs) due to the unusually large size and the multi-exonic structure of genes encoding muscle structural proteins, further highlighting the importance of...
|